CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Heska Corp  (HSKA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 


Heska Corp

HSKA's Fundamental analysis



You need to upgrade your Flash Player



Heska's sales fell by -13.61 % in II. Quarter 2018 from the same quarter a year ago. Ranking at No. 2881

Biotechnology & Drugs industry recorded growth of revenues by 3 %

Heska's net profit deacreased by -39.57 % in II. Quarter 2018 year on year, to $2 millions.

More on HSKA's Growth




Heska
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Company is currently trading with Price to Cash flow multiple of 87.73 in trailing twelve-month period.
Company
142.43
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 6.87.
Biotechnology & Drugs industry's Price to Sales ratio is at 5.65.

Heska Price to Book Ratio is at 7.94 higher than Indusry Avg. of 0, and higher than S&P 500 Avg. of -0

More on HSKA's Valuation

 Market Capitalization (Millions $) 873
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 127
 Net Income (TTM) (Millions $) 6
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) -2
 Total Debt (Millions $) 6
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover Ratio (TTM) 9
 Tangible Book Value (Per Share $) 13.78

 Market Capitalization (Millions $) 873
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 127
 Net Income (TTM) (Millions $) 6
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) -2
You need to upgrade your Flash Player
 Total Debt (Millions $) 6
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 9
 Tangible Book Value (Per Share $) 13.78

Profitability

Heska achieved increase in profitability, due to cost control. Operating Margin grew in II. Quarter 2018 to 7.43 % from 5.71 % in I. Quarter.

Heska net profit margin of 6.4 % is currently ranking no. 22 in Biotechnology & Drugs industry, ranking no. 128 in Healthcare sector and number 1734 in S&P 500.

More on HSKA's Key Ratios
You need to upgrade your Flash Player

You need to upgrade your Flash Player
  Ratio
   Capital Ratio (MRQ) 3.17
  Total Debt to Equity (MRQ) 0.05
  Tangible Leverage Ratio (MRQ) 0.26
  Asset Turnover Ratio (TTM) 0.93
  Inventory Turnover Ratio (TTM) 2.32


Heska achieved increase in profitability, due to cost control. Operating Margin grew in II. Quarter 2018 to 7.43 % from 5.71 % in I. Quarter.

Heska net profit margin of 6.4 % is currently ranking no. 22 in Biotechnology & Drugs industry, ranking no. 128 in Healthcare sector and number 1734 in S&P 500.

More on HSKA's Key Ratios


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SECI's Profile

Stock Price

SECI's Financials

Business Description

Fundamentals

Charts & Quotes

SECI's News

Suppliers

SECI's Competitors

Customers & Markets

Economic Indicators

SECI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071